BioSpace News Archive

Drug Development

GBT’s Sickle Cell Drug Shows Promise in Phase III Trial

Global Blood Therapeutics (GBT) reported the results of a review of Part A of its Phase III HOPE (Hemoglobin Oxygen Affinity Modulation to Inhibit HbS PolymErization) Study of voxelotor for sickle cell disease.

June 27, 2018
·
3 min read
·
Mark Terry
Business

Berlin Cures strengthens Business Advisory Board with the appointments of Ulf Berg, Ph.D., and Dragan Grabulovski, Ph.D.

Internationally Renowned Industry Veterans Provide Strategic Developmental Experience for the Company’s Transition to a Global Commercial Entity

June 27, 2018
·
4 min read
Drug Development

LYNPARZA® (olaparib) Significantly Delays Disease Progression in Phase 3 First-Line SOLO-1 Trial for Ovarian Cancer

LYNPARZA Met Primary Endpoint of Progression-Free Survival in Women with BRCA-Mutated Advanced Ovarian Cancer and Showed a Safety Profile Consistent with Previous Trials

June 27, 2018
·
15 min read
FDA

Pivot Pharma To File Investigational New Drug (IND) Application With U.S. FDA For PVT-005

Cannabinoid Topical Cream For Treatment Of Female Hypoactive Sexual Desire Disorder

June 27, 2018
·
5 min read
Business

Arcadia Biosciences and Farmer’s Business Network, Inc. Announce Partnership for Arcadia’s GoodWheat™

Collaboration will scale-up grower base for identity-preserved specialty wheat varieties and improve grower economics

June 27, 2018
·
4 min read
Job Trends

CIVANA Launches the Healers Vitality Program

CIVANA, the next generation wellness brand is extending to wellness industry professionals its Friends and Family Rate at its CIVANA Carefree Resort through its Healers Vitality Program.

June 27, 2018
·
2 min read
Drug Development

Axonics® Completes Enrollment of U.S. FDA Pivotal Study for its Sacral Neuromodulation System

ARTISAN-SNM is a 120-patient, single-arm, prospective clinical study designed to demonstrate the safety and effectiveness of the Axonics r-SNM System as an aid in the treatment of urinary dysfunction in patients who have failed or could not tolerate more conservative treatments.

June 27, 2018
·
3 min read
Business

Golden Meditech Announces FY2017/2018 Annual Results

Healthcare Services Business Achieves Organic Growth and Diversification

June 27, 2018
·
19 min read
Biotech Bay

AcelRx receives European Commission approval for DZUVEO™

AcelRx’s DZUVEO receives EU approval for management of acute moderate to severe pain in medically monitored settings

June 27, 2018
·
4 min read
Business

Kent Imaging Inc. and SerenaGroup announce Strategic Partnership in wound care

Partnership to jointly improve tissue assessment in wounds with the use of Near Infrared Imaging technology using Kent’s KD203 device.

June 27, 2018
·
3 min read